Home Newsfeeds Oppenheimer Downgrades Opendoor Technologies to Perform

Oppenheimer Downgrades Opendoor Technologies to Perform

Oppenheimer analyst Jason Helfstein downgrades Opendoor Technologies (NASDAQ:OPEN) from Outperform to Perform.

byBenzinga Newsdesk

February 27, 2023

1 minute read

Oppenheimer analyst Jason Helfstein downgrades Opendoor Technologies (NASDAQ:OPEN) from Outperform to Perform.

Vaxxinity Starts Dosing In Phase 1 Migraine Vaccine Trial

By Vandana Singh

September 13, 11:58 AM

Vaxxinity Inc (NASDAQ:VAXX) announced that the first subjects had been dosed in the Phase 1 clinical trial of UB-313, a vaccine…

VAXX

Phio Pharmaceuticals Has Received A Notice Of Allowance For Its U.S. Patent Application 16/680,101 Titled “RNA Duplexes With Single Stranded Phosphorothioate Nucleotide Regions For Additional Functionality (For Use In Gene Silencing)”.

By Benzinga Newsdesk

January 26, 2:49 PM

https://patentcenter.uspto.gov/applications/16680101/ifw/docs

PHIO

$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying

By Avi Kapoor

February 2, 9:56 AM

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

AVBP

Intelligent Bio Solutions Inc. Announces Exercise Of Previously Issued Warrants For $1.77M In Gross Proceeds

By Benzinga Newsdesk

February 5, 10:09 AM

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced an agreement between the Company

INBS

Oppenheimer Downgrades Opendoor Technologies to Perform

Related Posts

Vaxxinity Starts Dosing In Phase 1 Migraine Vaccine Trial

Phio Pharmaceuticals Has Received A Notice Of Allowance For Its U.S. Patent Application 16/680,101 Titled “RNA Duplexes With Single Stranded Phosphorothioate Nucleotide Regions For Additional Functionality (For Use In Gene Silencing)”.

$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying

Intelligent Bio Solutions Inc. Announces Exercise Of Previously Issued Warrants For $1.77M In Gross Proceeds